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Abstract
Exposures to life stressors accumulate across the lifespan, with possible impact on brain health. Little is known, however,
about the mechanisms mediating age-related changes in brain structure. We use a lifespan sample of participants
(n=21251; 4–97 years) to investigate the relationship between the thickness of cerebral cortex and the expression of the
glucocorticoid- and the mineralocorticoid-receptor genes (NR3C1 and NR3C2, respectively), obtained from the Allen Human
Brain Atlas. In all participants, cortical thickness correlated negatively with the expression of both NR3C1 and NR3C2 across
34 cortical regions. The magnitude of this correlation varied across the lifespan. From childhood through early adulthood,
the profile similarity (between NR3C1/NR3C2 expression and thickness) increased with age. Conversely, both profile
similarities decreased with age in late life. These variations do not reflect age-related changes in NR3C1 and NR3C2
expression, as observed in 5 databases of gene expression in the human cerebral cortex (502 donors). Based on the
co-expression of NR3C1 (and NR3C2) with genes specific to neural cell types, we determine the potential involvement of
microglia, astrocytes, and CA1 pyramidal cells in mediating the relationship between corticosteroid exposure and cortical
thickness. Therefore, corticosteroids may influence brain structure to a variable degree throughout life.
Introduction
Throughout the human lifespan, exposures to life stressors
accumulate with possible consequences for brain structure
and function, including mental health. Cumulative exposure to
stress and passing of time, namely aging, are intimately linked.
Stress has been associated with accelerated aging particularly
in the form of telomere shortening and age-related epigenetic
modifications (Epel et al. 2004; Shalev et al. 2013; Haussmann
and Heidinger 2015; Gassen et al. 2017). Additionally, aging
may result in a dysregulation of the hypothalamic-adrenal
pituitary (HPA) axis and reduced ability to adapt to stressors;
this phenomenon is commonly marked by a prolonged recovery
time in older adults (Sapolsky et al. 1986; Ferrari et al. 2001;
Seeman et al. 2001).
Glucocorticoids, the main mediators of the stress response,
are a class of corticosteroids with intracellular receptors capable
of both genomic (i.e., transcriptional) and non-genomic (e.g.,
membrane associated) activity (Prager and Johnson 2009; Menke
et al. 2012; Liston et al. 2013; Niwa et al. 2013; Arloth et al.
2015; Gassen et al. 2017; Zannas and Chrousos 2017). Within
the brain, there are 2 highly homologous corticosteroid recep-
tors through which glucocorticoids act: the abundant gluco-
corticoid receptor (GR), encoded by the NR3C1 gene, and the
less abundant mineralocorticoid receptor (MR), encoded by the
NR3C2 gene (Arriza et al. 1988). It is known that MR has a 10-
times greater affinity for glucocorticoids than GR (Reul and
De Kloet 1985; Arriza et al. 1988). This difference in receptor
affinity results in a dose effect wherebyMR and GR are occupied,
respectively, at low and high glucocorticoid levels. Although
highly lipophilic, the passage of corticosteroids across the blood
brain barrier is partially inhibited by the efflux transporter,
P-glycoprotein (Geerling and Loewy 2009). The crossing of some
corticosteroids (e.g., cortisol and aldosterone) is more hindered
than others (e.g., corticosterone; Geerling and Loewy 2009). Due
to higher concentrations, glucocorticoids outcompete mineralo-
corticoids for MR binding in brain tissue (Yongue and Roy 1987;
Arriza et al. 1988; Geerling and Loewy 2009). Moreover, MR is
thought to be constitutively occupied with high nuclear concen-
tration even at basal circulating levels of corticosteroids (Reul
and De Kloet 1985; Gesing et al. 2001). Activation of MR increases
neuronal excitability and elicits anti-apoptotic/neuroprotective
cellular effects. Conversely, GR activation can decrease neu-
ronal excitability and cause pro-apoptotic/deleterious cellular
effects (Almeida et al. 2000; Crochemore et al. 2005; Prager and
Johnson 2009; Sapolsky 2015). Thus, acting via ligand-bound
corticosteroid receptors, glucocorticoid exposure may induce
changes in brain structure detectable with magnetic resonance
imaging (MRI).
The variation in corticosteroid receptor gene expression
may result in differing susceptibility to glucocorticoid exposure.
In a previous study of the adolescent brain, we showed that
age-related decreases in cortical thickness were negatively
correlated with the expression of NR3C1 across 34 regions of
the cerebral cortex (Wong et al. 2017). We have also reported
that this relationship appears stronger in female adolescents
living in a potentially stressful social environment (Parker
et al. 2017). It is well established that cortical thinning occurs
during adolescence and continues into adulthood (Sowell
et al. 2007; Tamnes et al. 2010). This cortical thinning may, in
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Table 1 Cohort and gene expression source characteristics
Cohort Participant Demographics
Cohort Participants (n) Median age (range) Sex (%Male)
HRCa,c 1107 (454) 12.0 (6–18) 60.8
SYS (Adolescents)d 987 14.8 (12–19) 48.5
IMAGENa,d 1823 (1203) 14.9 (12–22) 47.7
BIL&GINd 453 24.0 (18–56) 48.8
HCPe 1200 29 (22–37) 45.6
LCBCa,c 1755 (986) 36.6 (4–93) 40.5
SYS (Parents)d 541 49.7 (36–65) 44.9
SHIP&TRENDd 3021 52.9 (21–90) 47.3
DLBSe 315 54.3 (20–89) 37.1
RSb,d 5720 (11 600 sim.) 63.0 (45–100) [64.1 (46–94) sim] 44.6
SALDe 494 64.0 (19–80) 37.9
MASd 358 64.5 (25–97) 28.9
FHSb,d 999 (1000 sim.) 64.0 (41–93) [64.1 (41–92) sim] 41.8
ASPS_Famd 332 68.1 (38–84) 39.2
OATSd 403 69.2 (65–97) 34.5
OASISa,e 671 (389) 69.5 (42–95) 39.5
3C_Dijond 436 72.2 (65–83) 42.0
LBC1936d 636 72.7 (71–74) 52.8
Gene Expression Databases
Source Donors (n) Median Age (range) Sex (%Male)
Allen Human Brain Atlas 6 42.5 (24–57) 83.3
BrainCloud 206 36.3 (4–78) 68.5
BrainEAC 134 57.9 (16–102) 73.9
BrainSpan 14 20.2 (4–40) 57.1
GTEx 142 57.9 (25–80) 69.7
HRC, Brazilian High Risk Cohort for Psychiatric Disorders; SYS, Saguenay Youth Study; BIL&GIN, Brain Imaging of Lateralization by the Groupe d’Imagerie Fonctionnelle;
LCBC, Lifespan Changes in Brain and Cognition; HCP, Human Connectome Project; SHIP&TREND, Study of Health in Pomerania and SHIP-TREND; DLBS, Dallas Lifespan
Brain Study; RS, Rotterdam Study; SALD, Southwest University Adult Lifespan Dataset; MAS, Memory and Aging Study; FHS, Framingham Heart Study; ASPS_Fam,
Austrian Stroke Prevention Study Family Cohort; OATS, Older Australian Twin Study; OASIS, Open Access Series of Imaging Studies; 3C_Dijon, The 3 City Study—Dijon
location; LBC1936, Lothian Birth Cohort.
aLongitudinal studies where participants n in brackets (column 2) represent the subsample of participants with more than 1 scan.
bSimulated data were used for both the Rotterdam and Framingham study. Therefore, number of participants andmedian age (and ranges) will have both an observed
sample value and a simulated value. Sim, based on simulated data.
cCollaborating cohort outside of the BRIDGET Consortium.
dCohorts included in the BRIDGET Consortium.
eCohorts with open access data.
part, be due to age-related reductions in dendritic and synaptic
complexity (Huttenlocher 1979; Nakamura et al. 1985; Kolb et al.
2003; Selemon 2013; Koss et al. 2014), a structural modification
also linked to glucocorticoid exposure (Vyas et al. 2002; Cook and
Wellman 2004; Liston andGan 2011; Liston et al. 2013). Therefore,
typically developing adolescents may exhibit glucocorticoid-
associated changes in cortical thickness. It is still unknown if
this association exists outside of the adolescent period.
The present investigation aims to examine the lifespan
association between corticosteroids and brain structure, namely
cortical thickness, using inter-regional variations in cortical
expression of NR3C1 and NR3C2 as a proxy of inter-regional
variations in response to corticosteroids. Here we use a
large, multi-cohort, lifespan sample (n=21251; age 4–97 years)
of individuals to investigate the relationship between the
inter-regional profile of cortical thickness, estimated from
MRI, and the inter-regional profile of NR3C1 and NR3C2
expression, obtained from the Allen Human Brain Atlas.
With cumulative exposure to glucocorticoids with aging, we
hypothesize that cortical thickness may become more strongly
associated with the distribution of NR3C1 and NR3C2 cortical
expression across the lifespan. Furthermore, we investigate
neural cell types that may be involved in mediating the
relationship between glucocorticoid exposure and cortical
thickness. Finally,we examinewhether expression ofNR3C1 and
NR3C2 in the human cerebral cortex varies across the lifespan,
using data from 502 post-mortem donor brains (4–102 years
of age).
Materials and Methods
Participants
A group of 18 international cohorts (14 cross-sectional), with a
combined total of 21 251 participants (54.9% female), contributed
data for this study. All cohorts contributed demographic (age
and sex) and neuroimaging data from cognitively healthy par-
ticipants across the lifespan (age range, 4–97 years). All included
participants had at least 1 T1-weighted brain scan. Basic demo-
graphic and cohort details can be found in Table 1.
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Figure 1. Creation of the NR3C1- (a) and NR3C2- (b) Thickness Similarity measure. Each measure starts from an individual-level correlation between regional cortical
thickness (in each of the 34 regions) and gene expression. Since gene expression is obtained from the Allen Human Brain Atlas, these values are constant across all
individuals. The individual-level correlations are pooled, Fisher-Z transformed, and then multiplied by negative 1 (inverted).
Neuroimaging
For each participant, cortical thickness was estimated for 34
cortical regions (left hemisphere) using the FreeSurfer pipeline
with the Desikan–Killiany Atlas (Desikan et al. 2006). We used
left hemisphere values of cortical thickness to ensure compati-
bility with gene expression data available in the Allen Human
Brain Atlas (left hemisphere only, see below). Note that inter-
regional profiles of cortical thickness in the right hemisphere
are virtually identical to those in the left hemisphere; in a
sample of 2091 participants (3514 scans), we observed a strong
correlation between the left and right inter-regional profiles
(r=0.99). Specifics on MRI protocol and FreeSurfer version can
be found in Supplementary Table S1.
Gene Expression
The Allen Human Brain Atlas provides mRNA expression from
multiple regions of the left hemisphere of 6 donor brains (age 24–
57 years, 1 female); mRNA was quantified using Agilent micro-
arrays, and each brain sample was mapped to MNI coordinates
(Supplementary, Hawrylycz et al. 2012; Mazziotta et al. 2001).
Using these data, French and Paus (2015) mapped gene expres-
sion to the 34 cortical regions parcellated using the Desikan–
KillianyAtlas. Briefly, 1) probe expression values (n=58692) were
averaged at the gene level (n=20737), 2) Freesurfer V5.3 was run
on the MNI152 template to map sample coordinates to Desikan–
Killiany Atlas regions, with anatomical annotations helping to
increase the number of correctlymapped samples, 3) each donor
had between 6 and 100 samples per region; therefore, gene
expression values were averaged at the regional level resulting
in a single expression value for each of the cortical region
(n=34), and 4) across the 6 donors, median gene expression was
calculated for each brain region. The final result is a single gene
expression (median) value for each of the 34 regions.
Given the lifespan nature of our study, we examined
whether NR3C1 and NR3C2 expression varies with age. To do
so, we obtained mRNA expression values from the following
(additional) sources of gene expression in the human brain:
BrainCloud (Supplementary, Colantuoni et al. 2012; Jaffe et al.
2015), Brain eQTL Almanac (BrainEAC; Trabzuni et al. 2011),
BrainSpan (Li et al. 2018), and Genotype Tissue Expression
(GTEx; Ardlie et al. 2015). Each source acquired tissue samples
from human post-mortem donor brains. The extent of tissue
sampling ranges from a single cortical region (BrainCloud) to 34
cortical regions (Allen Human Brain Atlas). When applicable, we
excluded donors younger than 4 years of age (the youngest
age in the in vivo MRI dataset). Across these datasets, the
age span was from 4 to 102 years. General demographics of
each source can be seen in Table 1. A description of each
database and information on data acquisition can be found
in Supplementary Table S2.
NR3C1- and NR3C2-Cortical Thickness Similarity
We assessed the degree of similarity in inter-regional profiles of
gene expression (Allen Human Brain Atlas) and inter-regional
profiles of cortical thickness (procedure depicted in Fig. 1). For
each participant, the 34 regional cortical thickness values were
correlated with NR3C1 expression (Allen Human Brain Atlas). By
design, values of cortical thickness varied across participants
while values of gene expression remained constant. Next, a
Fisher-Z transformation was applied to all correlation coeffi-
cients. For ease of interpretation, the Fisher-Z values were then
multiplied by negative 1; a higher value represents a greater
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similarity between inter-regional profiles of cortical thickness
and gene expression. The resulting values were then termed
NR3C1-Thickness Similarity. The same procedure was followed
forNR3C2 resulting in a distribution ofNR3C2-Thickness Similar-
ities (Fig. 1b). It is important to note that variations in theNR3C1-
and NR3C2-Thickness Similarity are solely due to individual
variations in the inter-regional profiles of cortical thickness.
The same (reference) values of NR3C1 and NR3C2 expression
(Table S3) are used in all individual-level correlations between
cortical thickness and gene expression across the 34 cortical
regions.
For the Framingham Heart Study (FHS) and the Rotterdam
Study (RS), gene thickness similarities were simulated from
sex-stratified and age-binned individual-level values to com-
ply with local data-sharing regulations. The simulation proce-
dure is outlined in Supplementary Table S4. Similarities in sim-
ulated and observed gene-thickness similarities were evaluated
using Kolmogorov–Smirnov tests of the distributions as well
as by a comparison of age coefficients (procedure outlined in
Supplementary Table S4). Age coefficients, from fitting observed
and simulated data, were highly comparable (Supplementary
Table S5; Supplementary Figs S1 and S2).
Co-expression of NR3C1 and NR3C2 Genes with
Cell-Specific Genes
We compared co-expression of NR3C1 and NR3C2 with gene
panels specific to the following 9 neural cell types, as identified
by Zeisel et al. (2015): astrocytes, CA1 pyramidal cells, endothe-
lial cells, ependymal cells, interneurons, microglia, mural cells,
oligodendrocytes, and S1 pyramidal cells. Included cell-specific
genes had to pass a 2-stage filter for reliability of gene expres-
sion profiles across the cerebral cortex, as described by Shin et al.
(2017). A resampling approach was used to test for significance
in co-expression profiles between NR3C1 (or NR3C2) and the
panel of genes specific to a cell type. For each cell-specific
panel of genes, a random sample, equal in size to the gene-
panel, was selected from all the genes in the Allen Human
BrainAtlas that passed the 2-stage filtering (n=2511). Expression
of each gene in the random sample was then correlated with
expression of the gene of interest (NR3C1 or NR3C2) and the
mean correlations coefficient was calculated (test statistic). This
random sampling and averaging of correlation coefficients was
repeated 10000 times for each panel of genes. The distribution
of the resulting mean values, 10000 per 9 cell-specific gene-
panels, comprised an empirical null distribution. The proportion
of the null distribution of means that exceed the observedmean
correlations ofNR3C1 (orNR3C2) with the true cell-specific panel
genes were used for a 2-sided P value at an FDR corrected
alpha=0.05.
Gene-Thickness Similarities that Increase with Age in
Late Life: Post-hoc Analysis
After observing a decline in both NR3C1- and NR3C2-Thickness
Similarities in late life, we investigated which other genes show
an age-related increase in association with cortical thickness
during the same time-period. In a subsample of participants
greater than 68 years old (start of NR3C1-Thickness Similarity
decline), the profiles of all 2511 genes that pass the 2-stage
consistency filtering were correlated with the profile of cortical
thickness. Next, we determined which of the gene-thickness
similarities increase with age. This was accomplished by cal-
culating the mean of each gene-thickness similarity and the
age-associated slope, derived from linear models adjusting for
sex and scanner site. There are 2 caseswhere the gene-thickness
similarity would on average increase with age: 1) if the mean
gene-thickness similarity was greater than zero and the slope
was positive or 2) if the mean gene-thickness similarity was
less than zero and the slope was negative. After identifying
those gene-thickness similarities that met either of the 2 cri-
teria, we conducted a gene ontology (GO) enrichment analysis.
The 2511 genes with consistent cortical profiles were used as
the background gene set, and GO group size was restricted to
<300 genes.
Statistical Analysis
To determine the effect of age on cortical thickness in each
of the 34 regions, we used generalized additive mixed models
(GAMMs; mgcv package in R Wood 2006) with a cubic spline
smoothing terms for age. Sex and scanner site were included
as fixed effects. GAMM fitting is well suited for estimating
non-linear trajectories—such as thickness estimates across the
lifespan—and is robust to changes in modeled parameters such
as age range (Storsve et al. 2014; Fjell et al. 2015; Vandekar
et al. 2015). To adjust for repeated measures and participant
kinship, random effects for participant ID and family ID were
included. We then tested the association between age and the
NR3C1- and NR3C2-Thickness Similarity with outliers defined
as greater than 3 standard deviations (SDs) from the mean. To
fit the lifespan trajectories, we again used a GAMM with sex
and scanner site included as fixed effects and participant ID
and family ID as random effects. The same procedure was used
to test the association between age and NR3C2-Thickness Sim-
ilarity. We compared NR3C1-Thickness Similarity with NR3C2-
Thickness Similarity by 1) overall mean and 2) rate of change
with age using first derivatives of the GAMM functions (gratia
package in R), in early (<28 years; peak inNR3C2-Thickness Simi-
larity) and late life (>68 years; initial-decline inNR3C1-Thickness
Similarity). To determine significance of these comparisons,
we used bootstrapped test statistics (10 000 iterations) where a
Gene-Thickness Similarity label was randomly assigned to each
participant prior to calculating the test statistics. Due to limited
overlap in sampled regions, NR3C1 and NR3C2 expression from
all 5 gene expression databases were scaled and pooled by
cerebral lobe (frontal, parietal, temporal, and occipital). Within
each of the lobes, we used linear mixed effect models with fixed
effects for age and sex as well as random effects for donor ID.
All statistical analyses were performed using R v3.5.1 (https://
www.r-project.org/), and reported significance values (P< 0.05)
are FDR corrected.
Results
A total of 21 251 participants, with 30143 T1-weighted scans,
were included in this study. Age ranged from 4.12 to 97.13 years
(mean=49.56, SD=23.38), and females comprised 54.86% of the
sample (Table 1).
Group-Level Analysis: Cortical Thickness and NR3C1
(NR3C2) Expression
Only studies that provided true estimates of cortical thickness
for each individual were included in this group-level analysis.
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This sample subset included 13793 participants (45.0% male)
with an age range between 4.12 and 97.13 [mean age=38.41
(±24.05) years]. All 34 cortical regions exhibited age-related vari-
ation in thickness across the lifespan (Supplementary Fig. S3;
Supplementary Table S6). Across these cortical regions, we
observed a strong negative correlation between NR3C1 expres-
sion and the group mean cortical thickness (R2 = 0.70, P<0.001)
as well as NR3C2 expression and the group mean cortical
thickness (R2 = 0.83, P<0.001; Supplementary Fig. S3).
Individual-Level Analysis: Cortical Thickness and
NR3C1 (NR3C2) Expression
All participants exhibited a negative correlation between cor-
tical thickness and NR3C1 (NR3C2) expression across the 34
cortical regions (Fig. 1). Thus, consistent with the group-level
pattern, cortical regions with highNR3C1 (NR3C2) expression are
thinner than regions with low expression.
Age-Related Changes in the NR3C1 (NR3C2) Thickness
Similarity
As explained above, each participant’s correlation coefficient
(thickness by gene expression across 34 regions) was Fisher-
Z transformed and multiplied by negative 1; a higher value
represents a greater similarity between inter-regional profiles
of cortical thickness and gene expression. The NR3C1-Thickness
Similarity varied in strength across the lifespan (F(7,30 143) = 243.8,
P<0.001; Fig. 2a). From childhood through early adulthood, we
observe an age-related increase in the NR3C1-Thickness Sim-
ilarity. Therefore, the inter-regional profile of cortical thick-
ness became more similar to the inter-regional profile of NR3C1
expression. This trend peaked at 30 years after which a relative
plateau is observed (Fig. 2a). At 68 years, we begin to see a
monotonic decrease inNR3C1-Thickness Similarity. Thus, in late
life, the inter-regional profile in cortical thickness departs from
the inter-regional profile of NR3C1 mRNA expression. Across
the lifespan,males had greaterNR3C1-Thickness Similarity than
females (beta=4.39e-03, P=0.021).
A similar lifespan trajectory was observed for the NR3C2-
Thickness Similarity (Fig. 2b; age, F(7,30 087) = 217.8, P<0.001).
Maturation of the cerebral cortex also resembled the distribution
of NR3C2 mRNA expression where NR3C2-Thickness Similarity
increased in early life (peak at age 27.9 years), plateaued
in midlife, and declined after 59.9 years. Females had a
greater NR3C2-Thickness Similarity than males (beta=2.01e-02,
P<0.001).
Differences in NR3C1- and NR3C2-Thickness Similarity
Despite the strong correlation between NR3C1 and NR3C2
expression across the 34 cortical regions (R2 = 0.75, P<0.001),
the 2 genes differed in the strength of association with
cortical thickness. On average, the NR3C2-Thickness Sim-
ilarity was stronger than the NR3C1-Thickness Similarity
(meandifference = 0.15, P<0.001) indicating that—across the 34
cortical regions—cortical thickness correlates more strongly
with NR3C2 (than NR3C1) expression. The first derivatives of
the GAMM lifespan trajectories (Supplementary Fig. S5) were
used to compare the rate of change in NR3C1- and NR3C2-
Thickness Similarity during the first few decades (increasing
similarity) and past few decades (decreasing similarity) of
the lifespan. The NR3C1-Thickness Similarity had a steeper
age-related increase in participants <28 years (meandifference =
2.34e-3, P<0.001). Thus, changes in cortical thickness appeared
to be more strongly associated with the distribution of
NR3C1 early in life. Conversely, participants >68 years dis-
played no difference in the rate of age-related decline in
NR3C1- andNR3C2-Thickness Similarity (meandifference = 8.98e-4,
P=6.41e-2).
Lifespan Variation in NR3C1 and NR3C2 Expression
A total of 502 donor brains (66.93% male) were included in this
analysis. Donor age ranged from 4 to 102 years (mean=47.25,
SD=20.19). Lobar NR3C1 expression did not change with age
(Fig. 3a). For NR3C2, only the frontal lobe displayed age-related
increases in expression,which appear to be confined to the early
years (Fig. 3b).
Additional analysis of age-related changes in gene expres-
sion was conducted for each sampled region of the 5 databases
(Supplementary Tables S8 and S9). None of the cortical regions
sampled displayed age-related changes in NR3C1 expression.
Expression of NR3C2 increased with age in 5 sampled regions
and decreased with age in 2 regions.
Co-expression of NR3C1 and NR3C2 with Cell-Specific
Genes
Both NR3C1 and NR3C2 were co-expressed negatively with the
majority of genes specific to astrocytes (74% and 72%, respec-
tively), CA1 pyramidal cells (72% for both), and microglia (69%
and 71%, respectively). Of the 3 cell types, CA1 pyramidal genes
had the strongest negative co-expression with both NR3C1 and
NR3C2 (Table 2).
Gene-Thickness Similarities that Increase with Age in
Late Life
In older participants (age>68) both NR3C1- and NR3C2-
Thickness Similarities decreased with age. Other biological
processes (non-corticosteroid mediated) may be involved.
Therefore, we tested for gene-thickness similarities that
increase with age in older participants. Of the 2511 genes with
consistent cortical profiles, 455 exhibited an increased gene-
thickness similarity with age. After conducting a GO enrichment
analysis on these 455 genes, no GO terms survived FDR
correction. The top 10 GO terms can be found in Supplementary
Table S10.
Finally, we compared the NR3C1- and NR3C2-Thickness
Similarities with those calculated for all other genes that
pass the 2-stage consistency filtering (nother = 2509). To do
so, we generated individual-level gene-thickness profile sim-
ilarities for all 2511 genes (2509 plus NR3C1 and NR3C2).
Next we calculated average gene-thickness profile similarities
for each gene within 3 age groups: young (age<27 years;
n=8080), middle-aged (age 27–60 years; n=9171), and elderly
(age>60 years; n=12892). The distribution of the 2511 values
of the average gene-thickness profile similarities can be seen
in Figure S6. Among the negatively correlated genes, NR3C1
ranked 140, 25, and 44 for the young, middle-aged, and elderly
groups, respectively (the top 12%; Fig. S6, dotted line). The
NR3C2-Thickness Similarity ranked 1, 1, and 7 for the young,
middle-aged, and elderly groups, respectively (the top 1%;
Fig. S6, solid line).
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Figure 2.NR3C1- andNR3C2-Thickness Similarity lifespan trajectoriesmodeled using GAMManalysiswith a cubic spline smoother for age.The 95% confidence intervals
(CIs) are shown in gray. For visualization with the inclusion of data points see Supplementary Figure S4. Both gene similarities show similar lifespan trajectories. (a)
Top: The NR3C1-Thickness Similarity increases rapidly during the first 2 decades of life before peaking at age 30 years. In contrast, at age 68 years there is a monotonic
declinewith age. Bottom:NR3C1-Thickness Similarity by agemodeled in each study separately. Study-specific statistics can be found in Supplementary Table S7. (b) The
NR3C2-Thickness Similarity increases rapidly during the first 2 decades of life before peaking at age 27.9. By age 59.9 years a monotonic decrease in NR3C2-Thickness
Similarity occurs. Bottom: NR3C2-Thickness Similarity by agemodeled in each study separately. Study-specific statistics can be found in Supplementary Table S7. HRC,
Brazilian High Risk Cohort for Psychiatric Disorders; SYS, Saguenay Youth Study; BIL_GIN, Brain Imaging of Lateralization by the Groupe d’Imagerie Fonctionnelle; LCBC,
Lifespan Changes in Brain and Cognition; HCP, Human Connectome Project; SHIP&TREND, Study of Health in Pomerania and SHIP-TREND; DLBS, Dallas Lifespan Brain
Study; RS, Rotterdam Study; SALD, Southwest University Adult Lifespan Dataset; MAS, Memory and Aging Study; FHS, Framingham Heart Study; ASPS_Fam, Austrian
Stroke Prevention Study Family Cohort; OATS, Older Australian Twin Study; OASIS, Open Access Series of Imaging Studies; 3C_Dijon, The 3 City Study - Dijon location;
LBC1936, Lothian Birth Cohort 1936.
Table 2 Inter-regional co-expression of NR3C1 and NR3C2 with cell-specific genes
Cell type Genes (n)
NR3C1 NR3C2
Avg. r p Corrected p (FDR) Avg. r p Corrected p (FDR)
Astrocyte 54 −0.34 2.00E-04 9.00E-04 −0.34 2.00E-04 9.00E-04
CA1 pyramidal 103 −0.26 1.00E-04 9.00E-04 −0.28 1.00E-04 9.00E-04
Endothelial 57 0.11 1.97E-01 2.53E-01 0.09 2.98E-01 3.83E-01
Ependymal 84 −0.11 1.33E-01 1.99E-01 −0.08 2.36E-01 3.54E-01
Interneuron 100 0.01 8.53E-01 8.53E-01 −0.02 8.29E-01 8.29E-01
Microglia 48 −0.27 5.70E-03 1.71E-02 −0.28 2.90E-03 8.70E-03
Mural 25 −0.11 4.13E-01 4.65E-01 −0.12 3.57E-01 4.02E-01
Oligodendrocyte 60 0.15 6.92E-02 1.25E-01 0.11 1.74E-01 3.13E-01
S1 Pyramidal 73 0.17 3.32E-02 7.47E-02 0.11 1.55E-01 3.13E-01
Avg.r, average correlation coefficient; FDR, false discovery rate corrected.
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Figure 3. Age-related variation in NR3C1 and NR3C2 mRNA expression from 5 pooled sources of human post-mortem gene expression databases (plotted with a cubic
smoother). (a) Expression of NR3C1 mRNA in the 4 cerebral lobes. Age did not predict NR3C1 expression in any of the cortical lobes (Frontal: F(3,493) = 3.64, P=0.15;
Parietal: F(1,19) = 0.01, P=0.95; Occipital: F(1,146) = 2.32, P=0.78; Temporal: F(1,139) = 0.21, P=0.95). Models with linear age terms fit all regions except the frontal lobe, which
had a cubic age term. (b) Expression of NR3C2mRNA in the 4 cerebral lobes. Age did not predict NR3C2 expression in the Parietal (F(3,19) = 2.16, PFDR = 2.80e-01), Occipital
(F(1,146) = 0.51, P=6.46e-01), or Temporal (F(1,139) = 2.41, P=2.80e-01) lobes. A cubic age term did predict NR3C2 expression in the Frontal lobe (F(3,493) = 25.74, P=2.00e-14).
Discussion
With a large sample of 21 251 participants, we investigated the
relationship between the inter-regional profile of cortical thick-
ness and the inter-regional profile of corticosteroid receptor
gene (NR3C1 and NR3C2) expression across the lifespan. In all
34 cortical regions, cortical thickness was associated strongly
with age. This is consistent with previous lifespan studies
(Salat et al. 2004). Additionally, we show that the cortical
profile of NR3C1 and NR3C2 mRNA expression was negatively
correlated with the profile of cortical thickness. Previous human
studies report associations between glucocorticoid exposure
and thinner cortex (Kremen et al. 2010; Davis et al. 2013).
Moreover, remodeling of dendritic and synaptic architecture is
involved in both typical aging (Huttenlocher 1979; Nakamura
et al. 1985; de Brabander et al. 1998) and glucocorticoid-
associated (Liston and Gan 2011) cortical thinning. Although
we cannot rule out the involvement of mineralocorticoids
in shaping cortical thickness, this is unlikely for several
reasons. Compared with glucocorticoids, mineralocorticoids
have much lower plasma levels and more restricted passage
across the blood brain barrier; for these reasons, glucocorticoids
outcompete mineralocorticoids in their binding to GR and
MR in brain tissue (Reul and De Kloet 1985; Yongue and
Roy 1987; Arriza et al. 1988; Rupprecht et al. 1993; Geerling
and Loewy 2009). Here we present some evidence that the
overlapping mechanisms of age- and glucocorticoid-related
cortical thinning may be mediated by the 2 corticosteroid
receptors.
The NR3C1-Thickness Similarity was on average stronger in
males than in females. This is consistent with our previous
study inwhich the inter-regional profile of age-related decreases
in cortical thickness showed a nominally stronger similarity in
male (R2 = 0.46) versus female (R2 = 0.30) adolescents (Wong et al.
2017). It is of note that, in the same study, the strongest decreases
in cortical thickness were found in cortical regions with high
expression of both AR and NR3C1 genes. This synergistic action
of AR and NR3C1 might be absent in case of NR3C2. This may
contribute to the opposite pattern of sex differences in the case
of the NR3C2-Thickness Similarity (Female>Male).
Our co-expression investigation of cell-specific genes
and NR3C1/NR3C2 help explain mechanisms involved in
glucocorticoid-associated cortical thinning. The majority of
genes associated with CA1 pyramidal cells, microglia, and
astrocytes are co-expressed negatively with both NR3C1/NR3C2.
Our previous study of adolescents used a similar technique
and identified the same 3 cell types as associated with cortical
thickness and thinning (Shin et al. 2017). The association of
genes specific to CA1 pyramidal cells with NR3C1 and NR3C2
supports the potential role of reduced dendritic complexity in
age- and glucocorticoid-related variations in cortical thickness.
Areas with greater dendritic complexity will likely require
more astrocyte support; dexamethasone, a synthetic glucocor-
ticoid, has been shown to block differentiation of astrocytes
(Sabolek et al. 2006). Activation of microglia is also negatively
regulated by glucocorticoids (Rivest 2009). The potential
reduction in astrocyte density and inactivation of microglia in
regions with high NR3C1 and NR3C2 expression may contribute
to the observed thinner cortex in these regions.
In the first few decades of life, a steeper increase in
NR3C1-Thickness Similarity, compared with NR3C2, suggests
the involvement of glucocorticoid-associated GR activation in
shaping cortical maturation. Similarly, our previous work, in
an adolescent sample, revealed a negative association between
NR3C1 mRNA expression and age-related decreases in cortical
thickness (Parker et al. 2017; Wong et al. 2017). Therefore,
stress may potentially play a role in the typical cortical
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thinning observed in early life. From childhood through to early
adulthood, there is a combination of a rapid decline in cortical
thickness (Gogtay et al. 2004; Raznahan et al. 2010; Tamnes
et al. 2010) concurrent with a unique blend of novel stress
exposures and increases in stress- and sex-hormone production
(Lupien et al. 2009; Eiland and Romeo 2013). The increased
glucocorticoid exposure may produce GR-mediated reductions
in neuronal excitation, dendritic and synaptic architecture,
and, to a lesser extent, cellular apoptosis (Almeida et al. 2000;
Crochemore et al. 2005; Radley 2005; Cerqueira et al. 2007;
Prager and Johnson 2009). On the other hand, the constitutively
occupied MR has been shown to be neuroprotective, to be anti-
apoptotic, and to increase neuronal excitability (Almeida et al.
2000; Crochemore et al. 2005; Prager and Johnson 2009). With
the transcription rate of the MR less than that of GR (Arriza
et al. 1988; Rupprecht et al. 1993), the net response may lead
to a relative reduction in dendritic and synaptic complexity.
Alterations in synapse and dendritic spine formation have been
associated with circadian peaks in circulating glucocorticoids
(potential GR role); conversely, maintenance of those structural-
alterations occurred during troughs/low levels of circulating
glucocorticoids (potential MR role; Liston and Gan 2011; Liston
et al. 2013). In addition, an MR:GR balance is suggested to be
critical for healthy neuronal activity (Sousa et al. 2008; Oitzl et al.
2010); this may extend to shaping and maintaining age-related
changes in cortical thickness.
Glucocorticoid exposure may play a role in shaping brain
maturation but brain aging may be governed by different biolog-
ical processes. In midlife, we observed little change in NR3C1-
or NR3C2-Thickness Similarity. There are several potential rea-
sons: by midlife, 1) there may be adequate stressor coping and
maintenance of an MR:GR balance; 2) a ceiling effect may occur,
limiting the degree of similarity between cortical thickness and
NR3C1/NR3C2 distribution; or 3) competing biological processes
may interfere with age-related increases in NR3C1- and NR3C2-
Thickness Similarity. In the seventh decade, the maintenance
of a strong NR3C1- or NR3C2-Thickness Similarity begins to
decline. That is, the inter-regional profile of cortical thickness no
longer resembles the distribution of the GRs mRNA expression
as tightly as during midlife. Dysregulation of the HPA axis and
a decrease in sensitivity to glucocorticoids are evident during
aging (Sapolsky et al. 1986; Ferrari et al. 2001; Seeman et al.
2001). This may disrupt the midlife-maintenance mechanisms
mentioned above (reason 1). In a study of stress-associated gene
expression, young rats exposed to the same thermic stressor
as older rats exhibited differential gene expression. Specifically,
older rats had a less induction of stress-response genes and
an increase in oxidative stress-associated genes (Zhang et al.
2002). Oxidative stress, denoted by the cellular accumulation
of free-radical by-products, is closely linked to aging (Lee et al.
2000; Terman and Brunk 2006).Moreover, neuro-inflammation is
strongly associated with aging (Lee et al. 2000). These are 2 late
life biological processes that may alter the strength of associa-
tion between the profile of cortical thickness and the profile of
NR3C1 (or NR3C2). Therefore, senescence is linked to disruption
of many biological processes, beyond the dysregulation of the
HPA axis, all of which may impact the patterned changes in
cortical thickness.
Here we used gene expression data, sampled from differ-
ent regions of the human cerebral cortex and deposited in 5
separate databases with over 500 post-mortem donor brains,
to show that the expression of NR3C1 and, with a few excep-
tions, also of NR3C2 do not change with age. This rules out
the potential confounding effect of age-related changes in gene
expression driving observed variations in NR3C1- or NR3C2-
Thickness Similarity with age. Previous studies have shown an
increase in NR3C1 mRNA expression in cerebral cortex with
age (Perlman et al. 2007; Sinclair et al. 2011). Our results may
vary due to differences in sample size, age range, and brain
regions sampled. Additionally, unlike previous studies, age was
modeled as continuous variable in our analysis. Also, increase in
NR3C1 and/orNR3C2 expression with age would likely result in a
lifespan strengthening of both theNR3C1- andNR3C2-Thickness
Similarity, which was not observed.
We acknowledge that there are various methods used
for mapping gene expression data to a brain atlas space.
Arnatkevic˘iu¯te˙ et al. (2019) have reviewed a number of
approaches (including the approach employed here) used for
relating gene expression data from the Allen Human Brain
Atlas to various neuroimaging datasets. As pointed out by
Arnatkevic˘iu¯te˙ et al. (2019), while valid, our original approach
did not include probes unassigned to an annotated gene and
did not filter probe expression based on their intensity. On
the other hand, we applied strict consistency criteria (profile
similarity across donors and atlases), which have minimized
possible technical sources of noise in the expression data.
Conclusions
The aim of this study was to determine the association between
corticosteroids and cortical thickness across the lifespan. This
was accomplished by using a large sample of participants in
conjunction with human post-mortem gene expression data
from several publicly available databases. The 2 corticosteroid
receptors may be involved in shaping the profile of cortical
thickness early in the lifespan. In midlife, there is a relative
maintenance of a strong association between cortical thickness
and corticosteroid receptor expression across the cerebral cor-
tex. In late life, this association deteriorates. The results suggest
that corticosteroids may influence brain structure to a varying
degree throughout life and, as such, may contribute to age- and
stress-related variations in cognitive functioning and mental
health.
Supplementary Material
Supplementary material is available at Cerebral Cortex online.
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